MacDonald M R, McCourt D W, Krause J E
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110.
J Biol Chem. 1988 Oct 15;263(29):15176-83.
We have used an in vitro transcription-translation system to study initial protein processing events of the rat substance P/neurokinin A gene products. cDNA clones for three different mRNA species, which are derived by differential RNA splicing, were subcloned into a plasmid, pGEM1, which contains the promoter for the bacteriophage SP6 RNA polymerase. In vitro synthesized mRNAs for alpha-, beta-, and gamma-preprotachykinin were translated in a wheat germ or rabbit reticulocyte cell-free system. When analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the translated protein products migrate consistent with the deduced molecular masses of alpha (13,035 Da)-, beta (15,003 Da)-, and gamma (13,343 Da)-preprotachykinin. The addition of dog pancreatic microsomal membranes to either cell-free translation system causes the production of a protease-resistant form of each of the three preprotachykinins which migrates with an apparent increase in molecular mass of approximately 2,000 Da. Each of these modified preprotachykinins lacks the putative signal peptide of the prepro- form, with signal peptidase cleavage occurring after the alanine residue at position 19. Both the prepro- and proforms of each tachykinin precursor molecule are recognized by antiserum R-140, an antiserum specific for the mid-portion of the undecapeptide substance P. The most likely explanation for the apparent increase in molecular mass is anomalous electrophoretic migration, since beta-preprotachykinin mRNA lacking the signal peptide encoding sequence is translated, in the absence of microsomal membranes, into a protein with the same apparent molecular mass as the modified form of beta-preprotachykinin. Therefore, each of the three preprotachykinin mRNAs are translatable, and their products are targeted to the secretory pathway by the presence of a cleavable signal peptide.
我们利用体外转录-翻译系统来研究大鼠P物质/神经激肽A基因产物的初始蛋白质加工事件。通过差异RNA剪接产生的三种不同mRNA种类的cDNA克隆被亚克隆到一个质粒pGEM1中,该质粒含有噬菌体SP6 RNA聚合酶的启动子。α-、β-和γ-前速激肽原的体外合成mRNA在小麦胚芽或兔网织红细胞无细胞系统中进行翻译。当通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析时,翻译后的蛋白质产物的迁移情况与推导的α(13,035道尔顿)-、β(15,003道尔顿)-和γ(13,343道尔顿)-前速激肽原的分子量一致。向任一无细胞翻译系统中添加犬胰腺微粒体膜会导致三种前速激肽原中的每一种产生一种抗蛋白酶形式,其迁移时分子量明显增加约2,000道尔顿。这些修饰后的前速激肽原中的每一种都缺乏前体形式的假定信号肽,信号肽酶在第19位丙氨酸残基后发生切割。每种速激肽前体分子的前体形式和前体形式都能被抗血清R-140识别,抗血清R-140是一种对十一肽P物质中部特异的抗血清。分子量明显增加的最可能解释是异常的电泳迁移,因为在没有微粒体膜的情况下,缺乏信号肽编码序列的β-前速激肽原mRNA被翻译成一种与修饰后的β-前速激肽原具有相同表观分子量的蛋白质。因此,三种前速激肽原mRNA中的每一种都可翻译,并且它们的产物通过可切割信号肽的存在被靶向到分泌途径。